
Sign up to save your podcasts
Or


Based on Podcast App listening data
Is patient confidentiality absolute or conditional? When does protecting privacy put others at risk? Can you follow a former patient in the EHR for learning? Should you post a compelling case online even if it’s “de-identified”? And when does the law force you to betray patient trust? In this episode of At the Bedside, learn how clinicians should act when ethics, law, and trust collide.
🔹 Sponsor: DoxGPT by Doximity - an AI assistant built with practicing clinicians to deliver bottom-line clinical answers, chart summaries, secure calls, and faxing directly inside the Doximity app. See how fast it is and how easy to read at DoxGPT.com
🔹Transcript and Shownotes:
03:51 | What is the difference between Privacy and Confidentiality?
05:50 | Guidelines and laws
10:06 | Limits/appropriate breaches (competing principles/obligations)
22:03 | Privacy vs education
35:34 | Conclusion
Baby alligators - those betrayals of purpose , or, death by a thousand paper cuts !
Check out our latest episode, where Dr. Eileen Barrett walks us through how to tackle baby alligators with:
Regulated curiosity
Strategic empathy
Small, well-chosen moves...
...and change that is big enough to matter, and small enough to win!
🔹 Sponsor: Caraway’s cookware set is a favorite for a reason.
For 10% off, go to Carawayhome.com/CoreIM or use code CoreIM at checkout.
🔹 Transcript & Shownotes
00:00 | What are “baby alligators” in medicine?
02:24 | Rifaximin & Workflow Fixes
14:17 | Verbal Orders Policy
18:39 | Micro Skills for Change
25:12 | Key Takeaways
#PhysicianBurnout #DoctorLife #HealthcareEfficiency, CoreIM, Internal Medicine, Career Development, Quality Improvement, QI
Gray zones of VTE management! How to approach anticoagulation duration in unprovoked, provoked-irreversible, and provoked-reversible clots?
When dose-reduced DOACs make sense for long-term secondary prevention? What truly constitutes DOAC failure? We also devle into how APLAS a critical do-not-miss diagnosis that changes management entirely.
🔹 Sponsor: Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: https://cme-info.nejm.org/core-im/
🔹 Transcript & Shownotes
(2:56) - (13:15) | PEARL 1: Managing clots in the “unprovoked”/provoked-irreversible patient
(13:21) - (18:10) | PEARL 2: Managing provoked, “reversible” clots
(18:14) - (25:14) | PEARL 3: DOAC failure: time to step it up?
(25:20) - (37:25) | PEARL 4: APLAS: the exception to everything
Tags: CoreIM, Internal Medicine, ClinicalPearls, Medical Education, IMCore, hospitalist, physician assistant, nurse practitioner, medical student, internal medicine, hematology
We hope these stories resonate with anyone who has felt pulled between professional purpose and personal life, and remind you that you’re not alone in wanting both.
🔹 Sponsor: Oakstone CME
Use the code "CORE30" for 30% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript and Shownotes
(1:09) | How the Horn Award Opened the Door to Growth in Dr. Tyra Fainstad’s Career and Life
(10:28) | How Dr. Carol Ward Created the Horn Award and Honored Mary Horn’s Legacy
(14:16) | Dr. Hilit Mechaber’s Story of Courage, Vision, and Impact Beyond the Award
(17:55) | Why does the Horn Award Matter?
Tags: CoreIM, Internal Medicine, Career Development Award, Mary O'Flaherty Horn Award, Clinical Care, Scholarship, Teaching, Leadership, Wellness and Care, Family Responsibilities
Antibiotic duration for bacteremia is something most of us learned by habit, not by trial data. In this episode, we walk through the BALANCE trial and use it as a lens to revisit how 1) host, 2) organism, and 3) source should guide treatment. When shorter really is enough, and when it isn’t?
🔹 Sponsor: Oakstone CME
Use the code "CORE30" for 30% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript and Shownotes
Timestamp
(02:58) | Host, Organism, Source: The Core Framework Behind Duration
(09:02) | How Evidence Shifted Practice
(11:27) | The BALANCE Trial: Short-Course vs Standard-Course Therapy
(18:55) | Where does this leave us?
Tags: CoreIM, Internal Medicine, Infectious disease, Evidence-Based Medicine, Clinical Reasoning, Hospital Medicine, Medical Education
How quickly can triglycerides rise? At what threshold are patients at risk of pancreatitis or cardiovascular adverse outcomes? What do you have to rule out? How do you counsel on lifestyle changes? Which medications do you start with why and when?
🔹 Transcript and Shownotes
(03:19) | Lipoprotein Lipase and Why Triglycerides Fluctuate Fast
(05:27) | Triglycerides as a Cardiovascular Risk Marker
(09:28) | Acute Management For Pancreatitis induced by Triglycerides
(14:34) | Lifestyle Counseling
(17:31) | Medications That Lower Triglycerides
(25:29) | How to Choose the Right Triglyceride Therapy
(27:56) | Genetic Causes and When to Suspect Familial Disorders
Tags: CoreIM, Internal Medicine, Lipidology, lipid, Cardiology, Metabolic Health, Triglycerides, Evidence-Based Medicine, Clinical Reasoning, Hospital Medicine, Medical Education, primary care
Why is venous congestion not the same as volume overload? How can looking at IVC as well as doppler on the hepatic vein, portal vein, and/or intrarenal vein help? Can venous congestion explain someone's delirium? Or be at play in septic shock? What are the limitations of the VEXUS score?
🔹 Sponsor: Oakstone CME
Use the code "CORE30" for 30% off: https://www.coreimpodcast.com/MKSAP
🔹Transcript and Shownotes
(00:00) | Volume overload vs. Venous Congestion
(05:49) | Venous Congestion and AKI, mortality, possible delirium
(10:10) | Measuring Venous Congestion and the Role of VEXUS
(15:05) | Common Mistakes and Best Practices of VEXUS score
(23:13) | Assessing Fluid Tolerance and Risks with Venous Doppler in Acute Care
(25:29) | Fluid vs. Vasopressor Strategy Guided by Venous Assessment
Tags: CoreIM, Internal Medicine, Critical Care, Nephrology, Cardiology, Fluid Management, POCUS, Ultrasound, Doppler, Hospital Medicine, Clinical Reasoning, Medical Education
SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?
🔹 Sponsor:
Use the code "CORE30" for 30% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript and Show Notes
Timestamps:
(01:43) | Case 1: Managing Uncontrolled Diabetes in a 47-Year-Old Male
(07:15) | Understanding Cost and Insurance Barriers in Diabetes Care
(09:26) | Case 2: Addressing Weight Gain and Financial Stress in a 52-Year-Old Male
(14:16) | Case 3: Managing Coronary Artery Disease and CKD in a 66-Year-Old Male
(19:41) | Case 4: Severe Obesity and Pain Management in a 59-Year-Old Female
(24:19) | Case 5: High A1C and Vascular Comorbidities in a 67-Year-Old Female
(35:34) | Weighing Side Effects and Practical Use of GLP-1 and SGLT2 Inhibitors
Tags: CoreIM, Primary Care, Endocrinology, Diabetes Mellitus, Type 2 Diabetes, Type 1 Diabetes, Metformin, GLP-1, SGLT2, Insulin, CGM, A1C, DKA, Medical Education, Clinical Reasoning, Hospital Medicine
What really works when treating HRS? Vasoconstrictors like terlipressin vs. norepinephrine vs. midodrine: how do we decide which to use? Do you give albumin? When do you give Lasix or another diuretic? When is the better choice transplant, dialysis, or even palliative care?
🔹 Sponsor: Oakstone CME
Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript & Show Notes
Timestamps:
(00:12) | Introduction and Overview of Hepatorenal Treatment
(03:38) | Vasoconstrictors Focus: Terlipressin, Norepinephrine, and Midodrine
(12:32) | Finding the Right Dose of Albumin and Knowing When to Stop
(15:06) | Volume Management: Balancing MAP, Diuretics, and Creatinine
(21:42) | Understanding the High Mortality of HRS-AKI
(32:30) | Transplant, Dialysis, or Palliation Care
Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Hepatorenal Syndrome, HRS-AKI, Cirrhosis, Nephrology, Liver Disease
HRS-AKI vs. other causes of AKI in cirrhosis: What do serum or urine sodium clues, albumin challenges, and shifting diagnostic criteria actually reveal about getting the diagnosis right?
🔹 Sponsor: Oakstone CME
Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP
🔹 Transcript & Show Notes
Timestamps:
(00:57) | Understanding the Pathophysiology of HRS
(03:42) | How Portal Hypertension Traps the Kidneys
(10:32) | Sorting the Differential of AKI in Cirrhosis Beyond HRS
(18:28) | Hyponatremia and Urine Sodium in Advanced Cirrhosis
(24:04) | Official Diagnosis and Evolving Criteria of HRS
(29:30) | Albumin: When It Helps and When to Hold Back
(34:00) | Recap and Future Directions
Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Nephrology, renal, hepatology, Portal Hypertension, Liver Disease
From the publisher's feed
Core Internal Medicine via following series: 5 Pearls || Clinically relevant pearls Mind the Gap || Why do we do what we do? Gray Matters || Management Reasoning Hoofbeats || Dissecting clinical…
Ranked by our users in the last 21 days

1,865 Listeners

319 Listeners

537 Listeners

697 Listeners

496 Listeners

254 Listeners

3,343 Listeners

271 Listeners

520 Listeners

372 Listeners

256 Listeners

431 Listeners

316 Listeners

327 Listeners

270 Listeners